| 臺大學術典藏 |
2022-08-19T00:20:28Z |
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives
|
Su Y.-Y.; Lin Y.-J.; Li C.-C.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:27Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Lin Z.-Z.; Hsu C.-H.; Liang P.-C.; Chen B.-B.; Shao Y.-Y.; CHIUN HSU; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-08-19T00:20:27Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
Lin Z.-Z.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Liang P.-C. |
| 臺大學術典藏 |
2022-08-19T00:20:26Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang F.-C.; Lin W.-C.; Chiang W.-C.; Chen T.W.-W.; Huang T.T.-M.; Liu J.-S.; Chen Y.-M.; CHIUN HSU; Yeh K.-H.; Chu T.-S. |
| 臺大學術典藏 |
2022-08-19T00:20:26Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
CHIUN HSU; Shao Y.-Y.; Chen C.-H.; Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.-H.; Lin Z.-Z.; Lu L.-C.; Liu T.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:20:25Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Jian C.-Z.; Ou P.-Y.; Ou D.-L.; Hsieh C.-H.; Lin L.-I.; Low G.-S.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:25Z |
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma
|
Liang P.-C.; Liu T.-H.; Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chen B.-B.; Shih T.T.-F.; Shen Y.-C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-19T00:20:24Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Yang S.-H.; Kuo S.-H.; Bai L.-Y.; Lee J.-C.; Chen B.-B.; CHIUN HSU |
| 臺大學術典藏 |
2022-08-19T00:20:24Z |
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature review
|
Huang Y.-H.; CHIUN HSU; Hsu C.-H.; Lin S.-M. |
| 臺大學術典藏 |
2022-08-19T00:20:23Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao Y.-Y.; Lin L.-I.; Ling A.; CHIUN HSU; Chen P.-S.; Lee B.-S.; Cheng A.-L.; Ou D.-L. |
| 臺大學術典藏 |
2022-08-19T00:20:19Z |
Effectiveness of tutor shadowing on faculty development in problem-based learning
|
Chao C.-T.; Ho C.-C.; Sheu B.-C.; Yang C.-W.; Tsai C.-L.; Chiu Y.-L.; Lin M.-W.; Chen H.-L.; CHIUN HSU |
| 臺大學術典藏 |
2022-06-17T01:46:49Z |
Fully digital problem-based learning for undergraduate medical students during the COVID-19 period: Practical considerations
|
Chao, Chia-Ter; Tsai, Chiao-Lin; Lin, Mong-Wei; Yang, Chih-Wei; Ho, Chao-Chi; Chen, Huey-Ling; CHIUN HSU; BOR-CHING SHEU |
| 臺大學術典藏 |
2022-06-14T23:24:22Z |
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
|
Yang, Shih Hung; JEN-CHIEH LEE; BANG-BIN CHEN; SUNG-HSIN KUO; CHIUN HSU; Bai, Li Yuan |
| 臺大學術典藏 |
2022-05-13T02:31:29Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang, Fan-Chi; Chen, Tom Wei-Wu; TAO-MIN HUANG; Lin, Wei-Chou; Liu, Jia-Sin; Chiang, Wen-Chih; Chen, Yung-Ming; CHIUN HSU; Yeh, Kun-Huei; Chu, Tzong-Shinn |
| 臺大學術典藏 |
2022-05-12T07:39:41Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh, Ching-Hung; Jian, Cheng-Zhe; LIANG-IN LIN; Low, Guan-Sian; Ou, Ping-Yun; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-12T07:37:59Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Yu-Yun; Chen, Pai-Sheng; LIANG-IN LIN; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-05T03:26:21Z |
Spectrum of cancer patients receiving renal biopsy
|
FAN-CHI CHANG; Chen, Tom Wei-Wu; Huang, Thomas Tao-Min; Lin, Wei-Chou; Liu, Jia-Sin; Chiang, Wen-Chih; Chen, Yung-Ming; CHIUN HSU; Yeh, Kun-Huei; Chu, Tzong-Shinn |
| 臺大學術典藏 |
2022-04-14T07:44:52Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
Shao, Yu-Yun; Kuo, Hung-Yang; Jeng, Yung-Ming; YAO-MING WU; Wang, Hsiu-Po; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2022-03-14T23:45:18Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
YU-YUN SHAO; Chen, Pai Sheng; LIANG-IN LIN; Lee, Bin Shyun; Ling, Andrew; ANN-LII CHENG; CHIUN HSU; DA-LIANG OU |
| 臺大學術典藏 |
2022-03-14T23:44:59Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
YU-YUN SHAO; HUNG-YANG KUO; YUNG-MING JENG; YAO-MING WU; HSIU-PO WANG; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey Chi; ANN-LII CHENG; Lin, Zhong Zhe |
| 臺大學術典藏 |
2022-01-24T06:05:36Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; CHIUN HSU; Hsieh C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; CHIUN HSU; Hsieh C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; CHIUN HSU; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma
|
Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; CHIUN HSU; Hsieh C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2022-01-24T06:05:34Z |
Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials
|
Chen B.-B.; Lin Z.-Z.; Shao Y.-Y.; CHIUN HSU; Hsieh C.-H.; Cheng A.-L.; Liang P.-C.; Shih T.T.-F. |
| 臺大學術典藏 |
2022-01-24T06:05:33Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang F.-C.; Chen T.W.-W.; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; CHIUN HSU; Yeh K.-H.; Chu T.-S. |
| 臺大學術典藏 |
2022-01-24T06:05:32Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh C.-H.; Jian C.-Z.; Lin L.-I.; Low G.-S.; Ou P.-Y.; CHIUN HSU; Ou D.-L. |
| 臺大學術典藏 |
2022-01-15T00:07:52Z |
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
|
Hsieh, Ching Hung; Jian, Cheng Zhe; LIANG-IN LIN; Low, Guan Sian; Ou, Ping Yun; CHIUN HSU; DA-LIANG OU |
| 臺大學術典藏 |
2022-01-15T00:07:49Z |
Fully digital problem-based learning for undergraduate medical students during the COVID-19 period: Practical considerations
|
CHIA-TER CHAO; Tsai, Chiao Lin; Lin, Mong Wei; CHIH-WEI YANG; CHAO-CHI HO; HUEY-LING CHEN; CHIUN HSU; BOR-CHING SHEU |
| 臺大學術典藏 |
2022-01-14T03:38:07Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; HUANG, PO-HSIANG; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Chiun Hsu |
| 臺大學術典藏 |
2021-12-16T03:39:19Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T03:25:51Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T02:03:28Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
BANG-BIN CHEN; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:29:31Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-11-24T08:20:52Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
Shao, Yu-Yun; Sun, Nai-Yun; Jeng, Yung-Ming; YAO-MING WU; CHIUN HSU; Hsu, Chih-Hung; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
YU-YUN SHAO; Sun, Nai Yun; YUNG-MING JENG; YAO-MING WU; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey Chi; ANN-LII CHENG; Lin, Zhong Zhe |
| 臺大學術典藏 |
2021-08-15T00:08:05Z |
Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma
|
BANG-BIN CHEN; YU-YUN SHAO; Lin, Zhong Zhe; CHIH-HUNG HSU; ANN-LII CHENG; CHIUN HSU; PO-CHIN LIANG; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-08-09T08:17:29Z |
Introduction of the EORTC Disease-Specific Quality of Life Questionnaires for Cancer Patients
|
Wei-Chu Chie; Chih-Hsin Yang; CHIUN HSU; Chia-Chun Lai |
| 臺大學術典藏 |
2021-08-06T03:59:35Z |
Group Report Contest Enhances Problem-Based Learning
|
Jeng-Yi Shieh; Chien-An Yao; CHIUN HSU; Shan-Chwen Chang; Fen-Yu Tseng |
| 臺大學術典藏 |
2021-08-06T03:52:20Z |
The Learning Experiences of Medical and Pharmacy Students Participating in Interdisciplinary Problem-Based Small-group Discussions
|
Chia-Hsuin Chang; CHIUN HSU; Chao-Chi Ho; Hsiu-Ying Wu; Ai-Tzu Li; Fen-Yu Tseng |
| 臺大學術典藏 |
2021-08-06T03:45:52Z |
Students' Perspective on the Key Elements and Effectiveness of Problem-based Learning Group Discussion
|
Chia-Hsuin Chang; CHIUN HSU; Chao-Chi Ho; Hsiu-Ying Wu; Ai-Tzu Li; Fen-Yu Tseng |
| 臺大學術典藏 |
2021-08-06T03:38:36Z |
Gap in the Intensity of End-of-Life Care between Younger and Older Taiwanese Adult Cancer Patients may not Reflect Younger Patients' Preferences
|
Siew-Tzuh Tang; Tsang-Wu Liu; Jyh-Ming Chow; Chang-Fang Chiu; CHIUN HSU; Li-Ni Liu; Su-Ching Kuo |
| 臺大學術典藏 |
2021-08-06T03:26:51Z |
Targeted Therapy for Hepatocellular Carcinoma
|
CHIUN HSU; Ying-Chun Shen; Ann-Lii Cheng |
| 臺大學術典藏 |
2021-07-15T05:31:54Z |
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives
|
Su, Yung Yeh; Li, Chia Chen; Lin, Yih Jyh; CHIUN HSU |
| 臺大學術典藏 |
2021-07-15T05:31:28Z |
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
|
Chia-Lang Hsu; DA-LIANG OU; Bai, Li Yuan; Chen, Chia Wei; Lin, Li; Huang, Shiu Feng; ANN-LII CHENG; YUNG-MING JENG; CHIUN HSU |
| 臺大學術典藏 |
2021-05-13T06:17:53Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang, Fan-Chi; Chen, Tom Wei-Wu; Huang, Thomas Tao-Min; Lin, Wei-Chou; Liu, Jia-Sin; WEN-CHIH CHIANG; Chen, Yung-Ming; CHIUN HSU; Yeh, Kun-Huei; Chu, Tzong-Shinn |
| 臺大學術典藏 |
2021-05-13T01:56:55Z |
Spectrum of cancer patients receiving renal biopsy
|
Chang, Fan-Chi; Chen, Tom Wei-Wu; Huang, Thomas Tao-Min; Lin, Wei-Chou; Liu, Jia-Sin; Chiang, Wen-Chih; YUNG-MING CHEN; CHIUN HSU; Yeh, Kun-Huei; Chu, Tzong-Shinn |
| 臺大學術典藏 |
2021-04-21T23:30:44Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen, Chia Wei; Chia-Lang Hsu; Chung, Chih Hung; Feng, Zi Rui; Lee, Bin Shyun; ANN-LII CHENG; Yang, Muh Hwa; CHIUN HSU |
